W.R. Grace & Co. (GRA) Tops Q1 EPS by 9c, Beats on Revenues; Raises FY18 EPS/Sales Views

W.R. Grace & Co. (NYSE: GRA) reported Q1 EPS of $0.82, $0.09 better than the analyst estimate of $0.73. Revenue for the quarter came in at $431.5 million versus the consensus estimate of $418.95 million.

• Net sales up 8.4%; Higher sales volumes and improved pricing in both segments; seventh consecutive quarter of year-over-year sales growth
• Diluted EPS of $0.64, up 1.6%; Adjusted EPS of $0.82, up 20.6%
• Completed strategic acquisition of polyolefin catalysts business on April 3
• Raising full-year 2018 sales and earnings guidance

GUIDANCE:

W.R. Grace & Co. sees FY2018 EPS of $3.85-$3.95, versus the consensus of $3.76.

For earnings history and earnings-related data on W.R. Grace & Co. (GRA) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Workhorse Group (WKHS) Misses Q2 EPS by 77c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c